AstraZeneca
Facts
as of Nov 21, 2026AstraZeneca is a British-Swedish pharmaceutical company formed in 1999 by the merger of Astra of Sweden and Zeneca of the United Kingdom, and now one of the largest drug makers in the world by revenue. Its portfolio is concentrated in oncology with Tagrisso, Imfinzi and Enhertu, alongside cardiovascular, renal and metabolic products including Farxiga, respiratory and immunology medicines, and a rare disease business built on the acquisition of Alexion. Headquartered in Cambridge in England and listed in London, Stockholm and New York, it reports in United States dollars.
It is hiring: 966 open roles, 585 of them posted in the last 30 days. Its stated pay is 14% above the market estimate for the same roles.
- Legal name
- ASTRAZENECA PLC
- Headquarters
- Cambridge, United Kingdom
- Founded
- 1999
- Employees
- 70,600astrazeneca.com · Dec 2019 · +9% in a year
- Revenue
- $58.7B2025 · SEC
- Legal entities
- 8 in 6 countries
- Subsidiaries
- 6 in 4 countriesUnited States 3, Finland 1, India 1, United Kingdom 1 · GLEIF
- Listing
- NYSE: AZN
- Open roles
- 966 in 134 citiesAlion job postings
- Register numbers
- CRN 02723534 · LEI PY6ZZQWO2IZFZC3IOL08
- Website
- astrazeneca.com
As of Nov 21, 2026, Alion lists 966 open roles at AstraZeneca. AstraZeneca is headquartered in Cambridge, United Kingdom. It was founded in 1999. The median pay stated in its open roles is $222k, across 220 postings that state pay.
Funding
Full ledger, 54 records →AstraZeneca returned $5.5B to shareholders in fiscal 2025 and paid $2.8B of income tax.
Ownership
All holders and entities →Astrazeneca Intermediate Holdings Limited holds 75–100% of AstraZeneca.
People
All open roles →966 open roles, 585 of them posted in the last 30 days. Its stated pay is 14% above the market estimate for the same roles.
Products
Products →AstraZeneca has 1 apps in the stores: 0 ratings and 5k+ downloads on Google Play.
Risk
Full record →AstraZeneca: an SBTi-validated climate target, 6,522 research papers in five years, 3 competition cases, $680k of EU lobbying in 2025, 519 federal court cases.
Peers
Compare →Ranked #3 by open roles among its 11 closest peers.
| # | Company | HQ | Open roles | Size | |
|---|---|---|---|---|---|
| 1 | Takeda Pharmaceutical | Tokyo, Japan | 1,144 | 5000+ | |
| 2 | AbbVie | North Chicago, United States | 1,139 | 5000+ | |
| 3 | AstraZeneca | Cambridge, United Kingdom | 966 | 5000+ | |
| 4 | Novartis | Basel, Switzerland | 653 | 5000+ |
